ALK B ALK-abello A/S Class B

Annual General Meeting in ALK-Abelló A/S held on 11 March 2020

Annual General Meeting in ALK-Abelló A/S held on 11 March 2020

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) held its annual general meeting on 11 March 2020.

The annual general meeting transacted the following business:

  • Adoption of the annual report 2019 and discharge of the Board of Directors and Board of Management.



  • No declaration of ordinary dividend.



  • Approval of the remuneration to the Board of Directors for the present year.



  • New election of Anders Hedegaard as Chairman of the Board of Directors.



  • Re-election of Lene Skole as Vice Chairman of the Board of Directors.



  • Re-election of Lars Holmqvist, Jakob Riis and Vincent Warnery to the Board of Directors.



  • New-appointment of PwC Statsautoriseret Revisionspartnerselskab as the company’s auditor.



  • Adoption of the following proposals from the Board of Directors:
    1. Amendment of the Articles of Association of Ingeniør Johannes Hansen’s Fond
    2. Approval of Remuneration policy
    3. Amendment of standard agenda
    4. Deletion of Article 5.7
    5. Matter of formality: amendment of registrar

                                                                 

                                                                 ALK-Abelló A/S



For further information please contact:

Anders Hedegaard, Chairman, tel.

Attachment

EN
11/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ALK-abello A/S Class B

Jesper Ingildsen
  • Jesper Ingildsen

ALK-Abello (Buy, TP: DKK190.00) - Expecting solid start to the year

We expect a solid Q1 report, with likely c11% organic growth as well as good margin progress supporting the 2025 guidance. Based on its footprint, we see minimal effect in case of tariffs on pharmaceuticals, with the biggest risk coming from potential reciprocal ones from Europe. We reiterate our BUY and DKK190 target price.

Alk-Abello A S: 1 director

A director at Alk-Abello A S bought 1,606 shares at 155.680DKK and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Jesper Ingildsen
  • Jesper Ingildsen

ALK-Abello (Buy, TP: DKK190.00) - Sales trump one-offs in Q4

While one-off costs took the initial focus (albeit broadly pre-warned), a solid underlying performance in Q4 was anchored in the important European tablet sales, which exceeded expectations. We find the 2025 guidance in line with expectations, but see upside risk to consensus on the top line given strong momentum in tablet sales in Europe. We reiterate our BUY and DKK190 target price.

Jesper Ingildsen
  • Jesper Ingildsen

ALK-Abello (Buy, TP: DKK190.00) - Expecting strong year end

We expect a strong Q4, with c12% organic revenue growth YOY, but the EBIT margin to be under pressure from well flagged one-offs related to optimisation initiatives and revision of its Chinese plans. We expect the 2025 guidance to be in line with expectations and its long-term strategy announced last year for >10% organic revenue growth and a c25% EBIT margin. We reiterate our BUY and DKK190 target price.

Jesper Ingildsen
  • Jesper Ingildsen

ALK-Abello (Buy, TP: DKK190.00) - Solid momentum reaffirmed

We find ALK’s solid momentum reaffirmed with the strong Q3 results, where higher European tablet sales more than offset the softness in SCIT/SLIT-drops. We believe the results also confirmed continued profitability improvement, leaving ALK on track to meet its 2025 EBIT margin target of c25% and in a position of strength to invest in growth opportunities, with the Neffy deal as a good example. We reiterate our BUY and DKK190 target price.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch